Compass is still being developed and is effectively in beta. Some content and features may be incomplete, change, or not work as expected.

Content is anchored to trusted sources where available, but Compass has not yet been clinically reviewed. It provides general information rather than medical advice.

Feedback helps us identify gaps, errors, usability problems and opportunities to improve Compass over time.

How Compass is developedGive feedback

The supplied study concerns Alzheimer’s disease rather than ALS or MND

Original source

Mitochondrial dysfunction and programmed cell death in Alzheimer's disease: A retrospective bioinformatics study.Medicine (Baltimore) · 20 March 2026 (opens in a new tab)

Compass summarised this from the study's abstract.

Study details

Studied in
Human, Computational

Related topics

A retrospective bioinformatics study examined mitochondrial dysfunction and programmed cell death in Alzheimer’s disease. It identified SOD1 and TOMM7 as candidate genes, but the source does not report an ALS or MND study.

Why this matters

This report does not establish a finding relevant to people living with ALS or MND. Its results are limited to analyses of Alzheimer’s disease datasets and do not show a treatment benefit.

Limitations and context

The source describes a retrospective computational analysis of Alzheimer’s disease datasets, not clinical research in ALS or MND. The reported drug links are predictions and would require laboratory and clinical testing.

Summarised by Compass 13 August 2026

This summary was generated by AI from the source listed above. It is not medical advice, so read the original source for anything that affects your care.

Bibliographic data from PubMed is courtesy of the U.S. National Library of Medicine. Compass does not reproduce source abstracts and may not reflect the most current record.

Relevant to you?